EQT AB acquires Life Sciences Partners - a leading European life sciences venture capital firm with approximately EUR 2.2 billion of assets under management and a team of 34 professionals. Life Sciences Partners will strengthen EQT’s position as one of the leading and most active private markets investors in the healthcare sector.
Loyens & Loeff advised EQT on this acquisition, with a team led by Antoinette van der Hauw and supported by Gearte Sijens, Anna van der Donk, Konstantina Antoniou, Freek Hilberdink, Erwin Bosma, Louis Lutz, Sandrine Lekkerkerker, Anne Remmers, Wendy Pronk, Sebastiaan Hooghiemstra, Sebastiaan Verkerk, Klaas Wiersma and Florentine Deur.
